Results 111 to 120 of about 14,564 (189)

Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]

J Clin Med
Jeong S, Seong SH, Sagong M.
europepmc   +1 more source

Real World Data About the Treatment of Wet Age-Related Macular Degeneration in Kuopio University Hospital During 2019-2021 Using a PRN Regimen. [PDF]

Clin Ophthalmol
Hiltunen TO, Kaarniranta K, Kivinen N.
europepmc   +1 more source

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials

, 2016
Patrick Oellers,1,2 Dilraj S Grewal,1,2 Sharon Fekrat1,2 1Duke Eye Center, Duke University Medical Center, 2Surgical Service, Durham Veterans Affairs Medical Center, Durham, NC, USA Abstract: For years, the standard of care for branch-retinal-vein ...
Oellers P, Grewal DS, Fekrat S
core  

Short-term efficacy of aflibercept 8 mg in refractory neovascular age-related macular degeneration: a retrospective case series from Taiwan. [PDF]

BMC Ophthalmol
Chi SC, Hwang DK, Chen SJ, Weng CC, Huang YM, Chou YB, Lin TC.   +6 more
europepmc   +1 more source

Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population. [PDF]

Drug Des Devel Ther
Qi Y, Cheng A, Xu J, Zhang C, Li S.
europepmc   +1 more source

Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]

Indian J Ophthalmol
Mishra C, Mohanty N, Purohit S, Orugonda U, Patil V.   +4 more
europepmc   +1 more source

Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape. [PDF]

Indian J Ophthalmol
Kannan NB, Vallinayagam M, Rishitha K, Ramasamy K.   +3 more
europepmc   +1 more source

OCCLUSIVE RETINAL VASCULITIS AFTER AFLIBERCEPT 8 mg INJECTION FOR WET MACULAR DEGENERATION. [PDF]

Retin Cases Brief Rep
Sisk RA.
europepmc   +1 more source

Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Shi J, Xu H, Zhao H, Zhao J, Chen L, Xu P, Jia D, Jiang C.   +7 more
europepmc   +1 more source

Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison. [PDF]

Adv Ther
Cortesi PA, Mezghani M, Alshaikheid M, Lunk I, D'Orsi MF, Zurria M, Bandello F.   +6 more
europepmc   +1 more source